Skip to main content
QNRX logo

QNRX · Quoin Pharmaceuticals Ltd. · Shareholders & Ownership

Track QNRX — free
$4.04 +0.06 (+1.51%) At close · Oct 20
Market Cap
$19.12M
Shares
4.80M
Volume · Oct 20 8067 Avg daily vol (3M) 536.55K

Every disclosed holder of QNRX in one list: 13F institutions, Schedule 13D and 13G filers, insiders (Forms 3, 4 and 5) and registered funds, each from its own latest filing. Holders nest by CIK and SEC reporting links, never by name, and each is summed once.

Who Owns QNRX

13F quarter Sep 30, 2026, combined view: filers that have not filed yet carry their Jun 30, 2026 positions
Holder group Shares % Out
Institutional (13F) 1,302,074 1.85%
Insiders (Forms 3, 4, 5) 0 0.00%
13D/G-only blocks 4,044,962 5.75%
Remaining 64,947,579 92.39%
Registered funds (N-PORT, not summed) 75,000 0.11%

Shares outstanding: 70,294,615, the issuer's latest cover-page count restated onto today's split basis.

Insiders are listed but not summed: the issuer has more than one class of common stock and Forms 3, 4 and 5 report one issuer-wide balance across them.

13D/G-only counts each filer's latest 13D or 13G that no 13F report of the listing contains, that names no 13F filer and that no counted insider files. Funds are never summed: their shares sit inside their advisers' 13F reports.

Holders of QNRX

# Holder Shares
1
Millennium Management LLC
13G CIK 1319244 · Unknown · May 26, 2026
Rule 13d-1(c), passive investor
3,850,385
2
Dauntless Investment Group, LLC
13F CIK 2044285 · Unknown · Jun 30, 2026
carried, not yet filed for the newest quarter
214,987
3
Ikarian Capital, LLC
13G CIK 1778253 · Registered investment adviser · Sep 30, 2026
Rule 13d-1(b), qualified institution, not summed
211,538
3.1
Ikarian Capital, LLC
13F CIK 1778253 · Registered investment adviser · Jun 30, 2026
carried, not yet filed for the newest quarter
211,538
4
Stonepine Capital Management, LLC
13F CIK 1440771 · Registered investment adviser · Jun 30, 2026
carried, not yet filed for the newest quarter
199,486
4.1
Stonepine Capital Management, LLC
Insider CIK 1440771 · Jan 29, 2026
10% Owner, issuer-wide, not summed
3,271,100
5
MILLENNIUM MANAGEMENT LLC
13F CIK 1273087 · Registered investment adviser · Jun 30, 2026
carried, not yet filed for the newest quarter
112,323
6
SummitTX Capital, L.P.
13F CIK 2052310 · Registered investment adviser · Jun 30, 2026
carried, not yet filed for the newest quarter
100,300
7
Woodline Partners LP
13F CIK 1784547 · Registered investment adviser · Jun 30, 2026
carried, not yet filed for the newest quarter
76,446
8
Aberdeen Group plc
13F CIK 1716774 · Holding company · Jun 30, 2026
carried, not yet filed for the newest quarter
75,000
9
Soleus Capital Management, L.P.
13F CIK 1802630 · Unknown · Jun 30, 2026
carried, not yet filed for the newest quarter
72,730
10
AIGH Capital Management LLC
13F CIK 1835943 · Unknown · Jun 30, 2026
carried, not yet filed for the newest quarter
70,000
11
BOOTHBAY FUND MANAGEMENT, LLC
13F CIK 1549230 · Registered investment adviser · Jun 30, 2026
carried, not yet filed for the newest quarter
59,838
12
ADAR1 Capital Management, LLC
13G CIK 1940272 · Registered investment adviser · Dec 31, 2025
Rule 13d-1(b), qualified institution
58,230
13
LANGER DENNIS
Insider CIK 1274225 · Aug 27, 2026
Director, issuer-wide, not summed
56,243
14
Resolute Capital Asset Partners LLC
13G CIK 1834913 · Registered investment adviser · Oct 10, 2025
Rule 13d-1(b), qualified institution
50,000
15
Culverwell Anthony James
Insider CIK 1693548 · Aug 31, 2026
Director, issuer-wide, not summed
40,364
16
Myers Michael
Insider CIK 1959547 · Aug 31, 2026
Director, Chief Executive Officer, issuer-wide, not summed
37,713
16.1
Michael Myers
13D CIK 1959547 · Unknown · Jan 27, 2025
26,835
17
Carter Denise P.
Insider CIK 1958621 · Aug 31, 2026
Director, Chief Operating Officer, issuer-wide, not summed
37,709
17.1
Denise Carter
13D CIK 1958621 · Unknown · Jan 27, 2025
26,835
18
abrdn Life Sciences Investors
Fund · Registered fund · Jun 30, 2026
abrdn Life Sciences Investors, not summed
34,600
18.1
abrdn World Healthcare Fund
Fund · Registered fund · Jun 30, 2026
abrdn World Healthcare Fund, not summed
40,400
19
Velan Capital Investment Management LP
13F CIK 1848809 · Registered investment adviser · Jun 30, 2026
carried, not yet filed for the newest quarter
32,372
20
ARMISTICE CAPITAL, LLC
13G CIK 1601086 · Registered investment adviser · Mar 31, 2025
Rule 13d-1(b), qualified institution
30,891
21
BARCLAYS PLC
13F CIK 312069 · Bank · Jun 30, 2026
carried, not yet filed for the newest quarter
21,469
22
Birchview Capital, LP
13F CIK 1618205 · Unknown · Jun 30, 2026
carried, not yet filed for the newest quarter
20,000
23
XTX Topco Ltd
13F CIK 1828301 · Unknown · Jun 30, 2026
carried, not yet filed for the newest quarter
15,006
24
Lawlor Sally Bridget
Insider CIK 2084407 · Aug 31, 2026
Chief Financial Officer, issuer-wide, not summed
10,684
25
MORGAN STANLEY
13F CIK 895421 · Holding company · Jun 30, 2026
carried, not yet filed for the newest quarter
8,000
26
UBS Group AG
13F CIK 1610520 · Bank · Jun 30, 2026
carried, not yet filed for the newest quarter
6,772
27
Dunn Gordon
Insider CIK 1958139 · Dec 23, 2024
Chief Financial Officer, issuer-wide, not summed
4,316
28
GAMMA Investing LLC
13F CIK 2010235 · Registered investment adviser · Sep 30, 2026
3,116
29
RHUMBLINE ADVISERS
13F CIK 1115418 · Registered investment adviser · Jun 30, 2026
carried, not yet filed for the newest quarter
2,332
30
Lind Global Fund II LP
13G CIK 1871665 · Unknown · Sep 30, 2024
Rule 13d-1(c), passive investor
1,786
31
SBI Securities Co., Ltd.
13F CIK 1851815 · Non-US institution · Jun 30, 2026
carried, not yet filed for the newest quarter
355
32
NISA INVESTMENT ADVISORS, LLC
13F CIK 937615 · Registered investment adviser · Sep 30, 2026
4

Shares are restated onto today's split basis. Change compares each row with the same holder's previous filing in the same source; a dash means there is none to compare. Nested 13D/G, insider and fund rows are not summed, since a 13F report already holds them.

Key facts CIK 1671502 CUSIP 74907L409 13F (30d) 2 filings 2 filers Visit website Investor relations